Everything below concerns Karl Fischer titration. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-11-29. Numbers and descriptions here follow the published literature rather than marketing material.
In the human body, creatine is synthesized mainly in the liver and kidneys from the amino acids glycine, arginine, and methionine. Dietary sources include meat, fish, and other animal tissues, which supply preformed creatine. Because plant foods contain little or no creatine, dietary intake varies widely among populations. The compound is stored largely in skeletal muscle, where it is converted to phosphocreatine and used to regenerate adenosine triphosphate during short bursts of activity.
Creatine monohydrate is one of several solid forms of creatine described in the literature. Other forms include anhydrous creatine, creatine hydrochloride, and creatine ethyl ester, each with different solubility and stability characteristics. The monohydrate is distinct from creatinine, a spontaneous breakdown compound that forms when creatine loses water and cyclizes. Commercial descriptions sometimes use synonyms such as methylguanidoacetic acid or N-(aminoiminomethyl)-N-methylglycine, which refer to the same base molecule. These names appear in chemical databases and product labels.
In dry solid form, creatine monohydrate is relatively stable when protected from moisture and heat. The crystal lattice includes water, and exposure to high humidity can cause caking or gradual changes in powder flow. Elevated temperatures may accelerate decomposition, particularly if moisture is present. Studies generally report that sealed, dry material retains acceptable purity for extended periods, although exact shelf life depends on packaging and storage conditions. Light exposure is not usually considered a major factor for this compound.
In aqueous solution, creatine monohydrate undergoes a slow conversion to creatinine, a cyclized degradation product. This reaction is pH- and temperature-dependent, and it proceeds faster in warm or alkaline conditions. Because the conversion is gradual, analytical measurements of creatine in solution must account for time and storage history. The equilibrium favors creatinine more strongly at higher temperatures, which is relevant to sample handling in laboratories and to beverage formulations. Refrigeration slows but does not entirely stop this process.
Quality assessment of creatine monohydrate typically uses high-performance liquid chromatography to separate creatine from creatinine and other impurities. Other methods include nuclear magnetic resonance spectroscopy, titration, and infrared spectroscopy for identity confirmation. Purity is often reported as a percentage of the labeled compound on a dry basis, while moisture content is measured separately. Because different analytical methods have different selectivity, comparing purity values across sources requires attention to the method and sample preparation.
| Property | Value | Notes |
|---|---|---|
| Chemical formula | C4H9N3O2·H2O | Monohydrate; anhydrous base is C4H9N3O2 |
| Molar mass | 149.15 g/mol | Calculated for the monohydrate form |
| Appearance | White crystalline powder | Typical laboratory and food-grade material |
| Solubility in water | Sparingly soluble at room temperature | Solubility increases with temperature |
| Common synonyms | Methylguanidoacetic acid; N-(aminoiminomethyl)-N-methylglycine | Synonyms refer to the creatine base, not the hydrate specifically |
Creatine monohydrate is the hydrated form of creatine, a nitrogen-containing organic acid involved in cellular energy transfer. Its molecular formula is C4H11N3O3, and it consists of creatine plus one water molecule in the crystal lattice. The anhydrous base, creatine, has the formula C4H9N3O2. The compound appears as a white, odorless, crystalline powder and is classified as a guanidine derivative. It is distinct from creatinine, a breakdown product measured in clinical chemistry.
In animals, creatine is synthesized mainly in liver, kidney, and pancreas from arginine, glycine, and methionine. The first committed step transfers a guanidino group from arginine to glycine, forming guanidinoacetate. Subsequent methylation by S-adenosylmethionine yields creatine. Dietary sources include meat and fish; endogenous synthesis supplies part of the body pool. Most creatine is stored in skeletal muscle, where it is converted to phosphocreatine and participates in rapid regeneration of adenosine triphosphate during short, intense activity.
Commercial creatine products appear in several forms, including monohydrate, hydrochloride, citrate, nitrate, and ethyl ester. Creatine monohydrate is the most studied form and serves as a reference material in comparative research. Different forms vary in solubility, pH, and water content, but they share creatine as the active moiety after dissolution. Claims that one form is uniformly superior remain debated, and study designs often differ in population, exercise protocol, and outcome measures. Purity and hydration state are central to interpreting product labels.
Manufacturing processes can leave trace amounts of dicyandiamide, creatinine, or residual solvents, depending on the synthetic route and purification steps. Heavy metals, arsenic, and microbial contamination are also monitored for food or pharmaceutical grades. Particle size distribution can affect dissolution behavior and blending uniformity, so it may be specified for certain applications. Analytical results are reported on a dry basis or as-is basis, and the difference matters when comparing certificates of analysis. Open questions remain about how minor impurities influence long-term stability under varied storage conditions.
Stability studies typically examine the effects of temperature, humidity, and light on creatine monohydrate. Sealed containers stored in cool, dry conditions help limit moisture uptake and hydrolysis. Elevated temperature and high relative humidity can accelerate conversion to creatinine, especially in aqueous solutions. In solid dosage forms, excipients and processing steps may also affect stability. Published stability data are not fully consistent across studies because test conditions and analytical methods vary.
== Production == In November 2024, Amazon MGM Studios was developing an action thriller film titled The Runner with Kevin Macdonald directing, Mark Gibson writing the script, and Gal Gadot starring. Principal photography began on 22 April 2025, in London and wrapped filming around early July 2025. London locations lensed include: Regent's Canal and St Pancras Way, in the London Borough of Camden; Kentish Town; Canary Wharf; Covent Garden; and Hampstead Heath. Some filming was on unclosed live streets, with real crowds and hidden cameras. The setting of Maia's route begins around Hampstead Heath, to Kentish Town, then along Regent's Canal, then down St Pancras Way, then toward King's Cross, London, and London King's Cross railway station. Later, in The City of London, sites include: Watling Street, Coleman Street, and King's Arms Yard. Later, in Canary Wharf and around the Thames river: Millennium Bridge, Waterloo Bridge and HMS Belfast. Through April and May 2025, eight pro-Palestinian protesters in total were arrested for disrupting the Central London set of the film. The film's production schedule, however, was not affected. The Metropolitan Police stated in a news release that the demonstrations were “solely because an actress involved in the production is Israeli." Gadot, who previously served in the IDF for two years, has been described as "vocal in her support of Israel".
In 1890, E. Welvert published a summary report on the old archives of the Seine department, destroyed in 1871. This report was compiled by an archivist from the Prefecture named Aubert. Discrepancies in dates appear between the two lists, and some parishes are missing from one or the other.
KATZEN HM, TIETZE F, STETTEN D (1963). "Further studies on the properties of hepatic glutathione-insulin transhydro-genase". J. Biol. Chem. 238 (3): 1006–11. doi:10.1016/S0021-9258(18)81250-9. PMID 14031343. Kohnert KD, Hahn HJ, Zuhlke H, Schmidt S, Fiedler H (1974). "Breakdown of exogenous insulin by Langerhans islets of the pancreas in vitro". Biochim. Biophys. Acta. 338: 68–77. doi:10.1016/0304-4165(74)90336-5.
Sources: en.wikipedia.org
In cell biology, ion trapping is the build-up of a higher concentration of a chemical across a cell membrane due to the pKa value of the chemical and difference of pH across the cell membrane. This results in basic chemicals accumulating in acidic bodily fluids such as the cytosol, and acidic chemicals accumulating in basic fluids.
=== Gene therapy === Gene therapy for hemoglobinopathies was first trialled in 2014 on a single patient with sickle cell disease (a fault in the beta globin gene), and followed by clinical trials in which a number of patients with either sickle cell or beta thalassemia were successfully treated. Gene therapies work by first harvesting the patient's HSCs, then using CRISPR gene editing to modify their DNA in the laboratory. In parallel with this, the person with thalassemia disease undergoes a myeloablation procedure (a form of chemotherapy) to destroy the remaining HSCs in their bone marrow. The laboratory treated cells are then infused back into the patient where they colonise the bone marrow and eventually commence production of healthy blood cells. There are fewer risks from this procedure than from HSCT, since the transplanted cells are autologous having originated from the patient herself/himself. There are two approved forms of gene therapy for beta thalassemia. Betibeglogene autotemcel, sold under the brand name Zynteglo, is a gene therapy for the treatment for beta thalassemia which adds a healthy beta-globin gene to the HSCs. It was approved for medical use in the United States in August 2022. The procedure involves collecting hematopoietic stem cells (HSCs) from the affected person's blood. In the laboratory, these HSCs then have a new gene for T87Q-globin (a modified beta-globin) introduced to them using a lentiviral vector.
In the heart it can cause myocardial infarction In the brain, it can cause a transient ischemic attack (TIA), and, in prolonged blood obstruction, stroke. Blockage of arteries that supply arms or legs may result in necrosis and gangrene Temporary or permanent decrease or loss of other organ functions In septic embolism, there can be infection of the affected tissue or even septic shock, potentially leading to gangrene and sepsis
Sources: en.wikipedia.org
Creatine monohydrate is the hydrated solid form of creatine, a nitrogen-containing compound involved in cellular energy metabolism. It consists of one creatine molecule associated with one water molecule in a crystal lattice.
No. Creatinine is a breakdown product formed when creatine loses water and cyclizes, and it is not the same compound. The two names are similar but refer to different chemical structures and roles.
The body synthesizes creatine from amino acids, mainly in the liver and kidneys. It also comes from animal foods such as meat and fish, while plant foods contain little or none.
Dry, sealed creatine monohydrate can remain stable for years, but storage conditions affect its shelf life. Moisture, heat, and repeated opening of containers can reduce quality over time.